Andreas Halvorsen - Viking Global Investors
Holding/activity history for BridgeBio Pharma Inc. (BBIO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 11,842,434 | 2.46 | Reduce 17.73% | 0.52 | $74.26 | $879,419,149 | SEC |
| 2025 Q4 | 14,393,934 | 2.92 | Reduce 9.91% | 0.21 | $76.49 | $1,100,992,012 | SEC |
| 2025 Q3 | 15,977,849 | 2.16 | Reduce 13.89% | 0.32 | $51.94 | $829,889,477 | SEC |
| 2025 Q2 | 18,555,375 | 2.32 | Reduce 15.87% | 0.38 | $43.18 | $801,221,093 | SEC |
| 2025 Q1 | 22,055,375 | 2.42 | Reduce 12.20% | 0.27 | $34.57 | $762,454,314 | SEC |
| 2024 Q4 | 25,120,991 | 2.23 | $27.44 | $689,319,993 | SEC | ||
| 2024 Q3 | 25,120,991 | 2.33 | $25.46 | $639,580,431 | SEC | ||
| 2024 Q2 | 25,120,991 | 2.45 | $25.33 | $636,314,702 | SEC | ||
| 2024 Q1 | 25,120,991 | 2.89 | $30.92 | $776,741,042 | SEC | ||
| 2023 Q4 | 25,120,991 | 3.72 | $40.37 | $1,014,134,407 | SEC | ||
| 2023 Q3 | 25,120,991 | 2.70 | Reduce 5.63% | 0.11 | $26.37 | $662,440,533 | SEC |
| 2023 Q2 | 26,620,991 | 1.88 | $17.20 | $457,881,045 | SEC | ||
| 2023 Q1 | 26,620,991 | 2.08 | $16.58 | $441,376,031 | SEC | ||
| 2022 Q4 | 26,620,991 | 1.02 | $7.62 | $202,851,951 | SEC | ||
| 2022 Q3 | 26,620,991 | 1.23 | $9.94 | $264,613,000 | SEC | ||
| 2022 Q2 | 26,620,991 | 1.11 | $9.08 | $241,719,000 | SEC | ||
| 2022 Q1 | 26,620,991 | 1.10 | $10.15 | $270,203,000 | SEC | ||
| 2021 Q4 | 26,620,991 | 1.29 | $16.68 | $444,038,000 | SEC | ||
| 2021 Q3 | 26,620,991 | 3.45 | $46.87 | $1,247,726,000 | SEC | ||
| 2021 Q2 | 26,620,991 | 4.93 | $60.96 | $1,622,816,000 | SEC | ||
| 2021 Q1 | 26,620,991 | 4.89 | $61.60 | $1,639,853,000 | SEC | ||
| 2020 Q4 | 26,620,991 | 5.22 | $71.11 | $1,893,019,000 | SEC | ||
| 2020 Q3 | 26,620,991 | 3.61 | $37.52 | $998,820,000 | SEC | ||
| 2020 Q2 | 26,620,991 | 3.75 | $32.61 | $868,111,000 | SEC | ||
| 2020 Q1 | 26,620,991 | 4.02 | $29.00 | $772,009,000 | SEC | ||
| 2019 Q4 | 26,620,991 | 4.37 | $35.05 | $933,066,000 | SEC | ||
| 2019 Q3 | 26,620,991 | 2.98 | $21.47 | $571,553,000 | SEC | ||
| 2019 Q2 | 26,620,991 | 3.22 | Buy | 3.22 | $26.97 | $717,968,000 | SEC |